GT Medical Technologies Welcomes New GammaTile® Center of Excellence Program Designation
GT Medical Technologies Welcomes New GammaTile® Center of Excellence Program Designation
PR Newswire
TEMPE, Ariz., Oct. 6, 2026
Recognizing exceptional leadership in patient education and clinical skill in the GammaTile procedure
TEMPE, Ariz., Oct. 6, 2026 /PRNewswire/ -- GT Medical Technologies, a company focused on improving the lives of patients with brain tumors, today announced St. Luke's Boise Medical Center as the latest GammaTile® Center of Excellence Program designation.
The program recognizes leaders in patient care dedicated to advancing brain tumor treatment. Physicians and their institutions who receive this designation have demonstrated an exceptional level of expertise in the GammaTile procedure by meeting specific clinical criteria, annual case minimums, and ongoing education requirements.
The following physicians are now recognized with achievement:
- Edward A. Duckworth, MD, Cranial Surgery, Neurointerventional Surgery, Neurosurgery, Skull Base Surgery
- David P. Bray, MD, Cranial Surgery, Neurosurgery
- Derek L. Martinez, MD, Cranial Surgery, Neurosurgery
- Benjamin G. McGahan, MD, Cranial Surgery, Neurosurgery
- Cameron S. Thorpe, MD, Radiation Oncology
- Tonya L. Kuhn, MD, Radiation Oncology
- Stephen C. Smith, MD, Radiation Oncology
- Timothy E. Sawyer, MD, Radiation Oncology
- Amy Geyer, MS, Medical Physicist
GammaTile is an innovative form of radiation therapy placed at the time of tumor removal surgery, delivering immediate, targeted radiation to the tumor site when cancer cells are at their lowest levels. Unlike conventional approaches, which often require a delay between surgery and radiation therapy to allow for wound healing, GammaTile eliminates this treatment gap. By delivering immediate, localized radiation directly at the tumor site, it is designed to maximize the treatment's effectiveness against remaining cancer cells and reduce the risk of regrowth.1
About GammaTile
GammaTile is FDA-cleared for newly diagnosed malignant (cancerous) and recurrent brain tumors and has been adopted by more than 150 leading centers across the United States, underscoring its growing acceptance in both academic and community healthcare settings.2 For more information, visit gammatile.com and follow @GammaTile on, Facebook, Instagram, LinkedIn and X.
About GT Medical Technologies, Inc.
GT Medical Technologies was founded by a dedicated team of brain tumor specialists to address unmet needs in brain tumor treatment. The company is committed to improving the lives of patients with brain tumors through innovative solutions that elevate the standard-of-care.
Media Contact
Dawn Fallon
New Dawn Communications LLC
Dfallon@newdawncomms.com
732-771-7808
References
- Garcia MA et al. J Neurooncol. 166:203-212 (2024).
- Data on file. GT Medical Technologies, Inc.
SOURCE GT Medical Technologies
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
These Overvalued Stocks Have Plenty of Room to Fall
The 10 Best Companies to Invest in Now
Your Year-End Financial Checklist: 5 Things to Tackle Before 2027
4 Big Impacts From the US Midterm Elections for Investors
United States